Harpoon Therapeutics
Merck & Co., Inc. is a research-intensive biopharmaceutical company committed to using leading-edge science to develop medicines and vaccines that save and improve lives worldwide. With a history spanning over 130 years, Merck operates responsibly to enable a safe, sustainable, and healthy future for all communities. The company focuses on innovation in areas such as oncology, vaccines, infectious diseases, cardio-metabolic disorders, immunology, neuroscience, and ophthalmology, and invests heavily in research and development to bring new therapies to market. Merck also emphasizes diversity, inclusion, and sustainability in its corporate culture and strategic initiatives.
Industries
Nr. of Employees
medium (51-250)
Harpoon Therapeutics
126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065 USA
Patents
Products
Vaccines and biologic therapies
Preventive and therapeutic vaccines and biologic medicines manufactured and distributed for public health and clinical use.
Small‑molecule and specialty medicines
Orally administered and injectable small‑molecule therapeutics across multiple therapeutic areas.
Veterinary pharmaceuticals, vaccines and connected animal‑health technologies
Veterinary vaccines, pharmaceuticals and connected technologies for identification, traceability and monitoring of animals.
Companion diagnostic and research tests
Assays and research‑use tests developed in collaboration to identify biomarkers and inform patient selection in clinical programs.
Investigational biologic modalities and next‑generation therapeutics
Development-stage modalities including antibody–drug conjugates, bispecific antibodies, RNA and oligonucleotide therapeutics being advanced through collaborations and internal programs.
Patient support programs and financial assistance
Programs to assist eligible patients with access to medications and educational resources to support treatment adherence.
Vaccines and biologic therapies
Preventive and therapeutic vaccines and biologic medicines manufactured and distributed for public health and clinical use.
Small‑molecule and specialty medicines
Orally administered and injectable small‑molecule therapeutics across multiple therapeutic areas.
Veterinary pharmaceuticals, vaccines and connected animal‑health technologies
Veterinary vaccines, pharmaceuticals and connected technologies for identification, traceability and monitoring of animals.
Companion diagnostic and research tests
Assays and research‑use tests developed in collaboration to identify biomarkers and inform patient selection in clinical programs.
Investigational biologic modalities and next‑generation therapeutics
Development-stage modalities including antibody–drug conjugates, bispecific antibodies, RNA and oligonucleotide therapeutics being advanced through collaborations and internal programs.
Patient support programs and financial assistance
Programs to assist eligible patients with access to medications and educational resources to support treatment adherence.
Services
Design, oversight and execution of clinical studies across phases with programs to improve trial diversity and patient recruitment.
Identification, negotiation and integration of external collaborations, licensing agreements and targeted acquisitions to expand pipeline and capabilities.
Large‑scale manufacturing operations, capacity expansion and global distribution for vaccines and biologic therapies.
24/7 patient and healthcare provider contact centers for adverse event reporting and product quality complaints, and patient financial assistance programs.
Development and deployment of ML‑powered clinical data layers, data integration and RWE analytics to inform development and retrospective analyses.
Partnerships to apply advanced bioengineering and synthetic biology approaches to improve active pharmaceutical ingredient manufacturing processes.
Design, oversight and execution of clinical studies across phases with programs to improve trial diversity and patient recruitment.
Identification, negotiation and integration of external collaborations, licensing agreements and targeted acquisitions to expand pipeline and capabilities.
Large‑scale manufacturing operations, capacity expansion and global distribution for vaccines and biologic therapies.
24/7 patient and healthcare provider contact centers for adverse event reporting and product quality complaints, and patient financial assistance programs.
Development and deployment of ML‑powered clinical data layers, data integration and RWE analytics to inform development and retrospective analyses.
Partnerships to apply advanced bioengineering and synthetic biology approaches to improve active pharmaceutical ingredient manufacturing processes.
Expertise Areas
- Clinical trial management and diversity in trials
- Vaccine development and biologics
- Oncology research and targeted biologics
- Infectious disease research
Key Technologies
- Machine learning‑powered clinical data layers
- Generative artificial intelligence for research
- Real‑world evidence analytics platforms
- Next‑generation companion diagnostic assay development